<DOC>
	<DOCNO>NCT01395615</DOCNO>
	<brief_summary>This observational study ass health relate quality life ( HQRL ) profile patient chronic lymphocytic leukaemia . Using health assessment questionnaire , data collect patient currently receive therapy finish therapy undergone assessment treatment .</brief_summary>
	<brief_title>An Observational Study The Health Related Quality Life Patients With Chronic Lymphocytic Leukaemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Patients chronic lymphocytic leukaemia Patients receive 1st line therapy Patients receive 2nd line therapy . This include patient previously respond well 1st line therapy ( relapse &gt; 12 month finish 1st line therapy ) receive therapy Within past three month , patient whose treatment stop 23 cycle 1st 2nd line therapy receive therapy Patients receive 3rd , 4th , 5th 6th cycle 1st 2nd line therapy Patients complete therapy , consider stable 312 month post therapy Eastern Cooperative Oncology Group ( ECOG ) performance status 01 Clinically significant disorder ( chronic lymphocytic leukaemia chronic lymphocytic comorbidities ) condition , include alcohol drug abuse , may interfere study participation affect study conclusion Mental disability significant mental illness , legal incapacity limited legal capacity Current high degree comorbid burden might affect accuracy quality life data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>